Assessment of endoscopic activity: Clinical trials and routine practice1st ECCO Endoscopy Workshop 2016
1
DOP001: Genetic and environmental risk model to predict intestinal inflammation in asymptomatic first-degree relatives of Crohn’s disease patientsECCO'16 DOP 2016
1
DOP003: Gene Expression Profiling Indicates Similar Molecular Pathways Are Active in Adult And Pediatric Ulcerative ColitisECCO'16 DOP 2016
1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2ECCO'16 DOP 2016
1
DOP006: Gut homing adipose tissue T-cells might influence intestinal barrier function in Crohn’s disease and obesityECCO'16 DOP 2016
1
DOP007: Interleukin-10 inhibits human IFN#CHR:gamma_LOWER# and IL-17-producing T helper cells indirectly by controlling antigen-presenting cell functionECCO'16 DOP 2016
1
DOP009: An autoimmunity-associated variant in PTPN22 protects from disease onset in mouse models of colitisECCO'16 DOP 2016
1
DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history?ECCO'16 DOP 2016
1
DOP012: Do ulcerative colitis patients treated withcorticosteroids at diagnosis really have a more aggressive disease course?ECCO'16 DOP 2016
1
DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohn’s diseaseECCO'16 DOP 2016
1